Copyright Reports & Markets. All rights reserved.

Global Biologics & Biosimilars Sales Market Report 2020 by Manufacturer, Region, Type and Application

Request for Sample of this report
Buy now

Table of Contents

    1 Executive Summary

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Biologics & Biosimilars Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Antibiotic
      • 2.1.2 Enzyme
      • 2.1.3 Hormone
      • 2.1.4 Non-Patented Biological Reagents
      • 2.1.5 Other
    • 2.2 Overall Market Performance(Value)
      • 2.2.1 Antibiotic
      • 2.2.2 Enzyme
      • 2.2.3 Hormone
      • 2.2.4 Non-Patented Biological Reagents
      • 2.2.5 Other

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Tumor
      • 3.1.2 Diabetes
      • 3.1.3 Cardiovascular
      • 3.1.4 Hemophilia
      • 3.1.5 Other

    4 Manufacturers Profiles/Analysis

    • 4.1 fizer
      • 4.1.1 fizer Profiles
      • 4.1.2 fizer Product Information
      • 4.1.3 fizer Biologics & Biosimilars Sales, Sales Value(Million USD), Price and Gross Profit
      • 4.1.4 fizer SWOT Analysis
    • 4.2 Roche
      • 4.2.1 Roche Profiles
      • 4.2.2 Roche Product Information
      • 4.2.3 Roche Biologics & BiosimilarsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.2.4 Roche SWOT Analysis
    • 4.3 Amgen
      • 4.3.1 Amgen Profiles
      • 4.3.2 Amgen Product Information
      • 4.3.3 Amgen Biologics & BiosimilarsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.3.4 Amgen SWOT Analysis
    • 4.4 AbbVie
      • 4.4.1 AbbVie Profiles
      • 4.4.2 AbbVie Product Information
      • 4.4.3 AbbVie Biologics & BiosimilarsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.4.4 AbbVie SWOT Analysis
    • 4.5 Sanofi
      • 4.5.1 Sanofi Profiles
      • 4.5.2 Sanofi Product Information
      • 4.5.3 Sanofi Biologics & BiosimilarsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.5.4 Sanofi SWOT Analysis
    • 4.6 Johnson & Johnson
      • 4.6.1 Johnson & Johnson Profiles
      • 4.6.2 Johnson & Johnson Product Information
      • 4.6.3 Johnson & Johnson Biologics & BiosimilarsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.6.4 Johnson & Johnson SWOT Analysis
    • 4.7 Novo Nordisk
      • 4.7.1 Novo Nordisk Profiles
      • 4.7.2 Novo Nordisk Product Information
      • 4.7.3 Novo Nordisk Biologics & BiosimilarsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.7.4 Novo Nordisk SWOT Analysis
    • 4.8 Novartis
      • 4.8.1 Novartis Profiles
      • 4.8.2 Novartis Product Information
      • 4.8.3 Novartis Biologics & BiosimilarsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.8.4 Novartis SWOT Analysis
    • 4.9 Merck
      • 4.9.1 Merck Profiles
      • 4.9.2 Merck Product Information
      • 4.9.3 Merck Biologics & BiosimilarsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.9.4 Merck SWOT Analysis
    • 4.10 Lilly
      • 4.10.1 Lilly Profiles
      • 4.10.2 Lilly Product Information
      • 4.10.3 Lilly Biologics & BiosimilarsSales, Sales Value (Million USD), Price and Gross Profit
      • 4.10.4 Lilly SWOT Analysis
    • 4.11 3sbio
    • 4.12 Changchun High Tech
    • 4.13 CP Guojian Pharmacy
    • 4.14 Biotech Pharma
    • 4.15 Gelgen Biopharma
    • 4.16 Sandoz
    • 4.17 Teva
    • 4.18 Hospira
    • 4.19 Mylan

    5 Market Performance for Manufacturers

    • 5.1 Global Biologics & Biosimilars Sales (K Units) and Market Share by Manufacturers 2014-2020
    • 5.2 Global Biologics & Biosimilars Revenue (M USD) and Market Share by Manufacturers 2014-2020
    • 5.3 Global Biologics & Biosimilars Price (USD/Unit) of Manufacturers 2014-2020
    • 5.4 Global Biologics & Biosimilars Gross Margin of Manufacturers 2014-2020
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 China Market Performance for Manufacturers
      • 6.1.1 China Biologics & Biosimilars Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.1.2 China Biologics & Biosimilars Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.1.3 China Biologics & Biosimilars Price (USD/Unit) of Manufacturers 2014-2020
      • 6.1.4 China Biologics & Biosimilars Gross Margin of Manufacturers 2014-2020
      • 6.1.5 Market Concentration
    • 6.2 USA Market Performance for Manufacturers
      • 6.2.1 USA Biologics & Biosimilars Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.2.2 USA Biologics & Biosimilars Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.2.3 USA Biologics & Biosimilars Price (USD/Unit) of Manufacturers 2014-2020
      • 6.2.4 USA Biologics & Biosimilars Gross Margin of Manufacturers 2014-2020
      • 6.2.5 Market Concentration
    • 6.3 Europe Market Performance for Manufacturers
      • 6.3.1 Europe Biologics & Biosimilars Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.3.2 Europe Biologics & Biosimilars Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.3.3 Europe Biologics & Biosimilars Price (USD/Unit) of Manufacturers 2014-2020
      • 6.3.4 Europe Biologics & Biosimilars Gross Margin of Manufacturers 2014-2020
      • 6.3.5 Market Concentration
    • 6.4 Japan Market Performance for Manufacturers
      • 6.4.1 Japan Biologics & Biosimilars Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.4.2 Japan Biologics & Biosimilars Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.4.3 Japan Biologics & Biosimilars Price (USD/Unit) of Manufacturers 2014-2020
      • 6.4.4 Japan Biologics & Biosimilars Gross Margin of Manufacturers 2014-2020
      • 6.4.5 Market Concentration
    • 6.5 Korea Market Performance for Manufacturers
      • 6.5.1 Korea Biologics & Biosimilars Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.5.2 Korea Biologics & Biosimilars Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.5.3 Korea Biologics & Biosimilars Price (USD/Unit) of Manufacturers 2014-2020
      • 6.5.4 Korea Biologics & Biosimilars Gross Margin of Manufacturers 2014-2020
      • 6.5.5 Market Concentration
    • 6.6 India Market Performance for Manufacturers
      • 6.6.1 India Biologics & Biosimilars Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.6.2 India Biologics & Biosimilars Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.6.3 India Biologics & Biosimilars Price (USD/Unit) of Manufacturers 2014-2020
      • 6.6.4 India Biologics & Biosimilars Gross Margin of Manufacturers 2014-2020
      • 6.6.5 Market Concentration
    • 6.7 Southeast Asia Market Performance for Manufacturers
      • 6.7.1 Southeast Asia Biologics & Biosimilars Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.7.2 Southeast Asia Biologics & Biosimilars Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.7.3 Southeast Asia Biologics & Biosimilars Price (USD/Unit) of Manufacturers 2014-2020
      • 6.7.4 Southeast Asia Biologics & Biosimilars Gross Margin of Manufacturers 2014-2020
      • 6.7.5 Market Concentration
    • 6.8 South America Market Performance for Manufacturers
      • 6.8.1 South America Biologics & Biosimilars Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.8.2 South America Biologics & Biosimilars Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.8.3 South America Biologics & Biosimilars Price (USD/Unit) of Manufacturers 2014-2020
      • 6.8.4 South America Biologics & Biosimilars Gross Margin of Manufacturers 2014-2020
      • 6.8.5 Market Concentration

    7 Global Biologics & Biosimilars Market Assessment by Regions (2014-2020)

    • 7.1 Global Biologics & Biosimilars Sales (K Units) and Market Share by Regions 2014-2020
    • 7.2 Global Biologics & Biosimilars Revenue (M USD) and Market Share by Regions 2014-2020
    • 7.3 Global Biologics & Biosimilars Price (USD/Unit) by Regions 2014-2020
    • 7.4 Global Biologics & Biosimilars Gross Margin by Regions 2014-2020

    8 Development Trend for Regions

    • 8.1 Global Biologics & Biosimilars Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.2 China Biologics & Biosimilars Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.3 USA Biologics & Biosimilars Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.4 Europe Biologics & Biosimilars Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.5 Japan Biologics & Biosimilars Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.6 Korea Biologics & Biosimilars Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.7 India Biologics & Biosimilars Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.8 Southeast Asia Biologics & Biosimilars Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.8 Southeast Asia Biologics & Biosimilars Sales and Growth, Sales Value and Growth Rate 2014-2020

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Manufacturing Plants Distribution

    11 Consumer Analysis

    • 11.1 Tumor Industry
    • 11.2 Diabetes Industry
    • 11.3 Cardiovascular Industry
    • 11.4 Hemophilia Industry
    • 11.5 Other Industry

    12 Market Forecast 2021-2026

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
      • 12.1.1 Global Biologics & Biosimilars Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
      • 12.1.2 Global Biologics & Biosimilars Sales (K Units) and Growth Rate 2021-2026
      • 12.1.3 China Biologics & Biosimilars Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.4 USA Biologics & Biosimilars Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.5 Europe Biologics & Biosimilars Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.6 Japan Biologics & Biosimilars Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.7 Korea Biologics & Biosimilars Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.8 India Biologics & Biosimilars Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.9 Southeast Asia Biologics & Biosimilars Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.10 South America Biologics & Biosimilars Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
    • 12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2021-2026
      • 12.2.1 Overall Market Performance
      • 12.2.2 Antibiotic
      • 12.2.3 Enzyme
      • 12.2.4 Hormone
      • 12.2.5 Non-Patented Biological Reagents
      • 12.2.6 Other
    • 12.3 Sales (K Units) Forecast by Application 2021-2026
      • 12.3.1 Overall Market Performance
      • 12.3.2 Tumor
      • 12.3.3 Diabetes
      • 12.3.4 Cardiovascular
      • 12.3.5 Hemophilia
      • 12.3.6 Other
    • 12.4 Price (USD/Unit) and Gross Profit
      • 12.4.1 Global Biologics & Biosimilars Price (USD/Unit) Trend 2021-2026
      • 12.4.2 Global Biologics & Biosimilars Gross Profit Trend 2021-2026

    13 Conclusion

    In this report, our team research the global Biologics & Biosimilars market by type, application, region and manufacturer 2014-2020 and forcast 2021-2026. For the region, type and application, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.

    Geographically, this report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Biologics & Biosimilars for these regions, from 2014 to 2026 (forecast), covering
    China
    USA
    Europe
    Japan
    Korea
    India
    Southeast Asia
    South America

    Global Biologics & Biosimilars market competition by top manufacturers/players, with Biologics & Biosimilars sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
    fizer
    Roche
    Amgen
    AbbVie
    Sanofi
    Johnson & Johnson
    Novo Nordisk
    Novartis
    Merck
    Lilly
    3sbio
    Changchun High Tech
    CP Guojian Pharmacy
    Biotech Pharma
    Gelgen Biopharma
    Sandoz
    Teva
    Hospira
    Mylan
    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Antibiotic
    Enzyme
    Hormone
    Non-Patented Biological Reagents
    Other
    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Biologics & Biosimilars for each application, including
    Tumor
    Diabetes
    Cardiovascular
    Hemophilia
    Other

    If you have any special requirements, please let us know and we will offer you the report as you want.
    Buy now